The daily Wall Street recruiting brief. Five minutes of market context, the storylines worth repeating in interviews, and the framing that turns a headline into an answer.
S&P 500 Hits New High on Apple Earnings as Oil Climbs on Iran Tensions. U.S. equities are trading higher at midday, with the S&P 500 advancing 0.62 percent to 7,253.47 and the Nasdaq up more than 1 percent, both marking new intraday highs after the best month since 2020. Apple shares are surging nearly 5 percent after the company delivered better-than-expected results on strong iPhone sales and China demand, underscoring continued AI and tech momentum. The gains persist even as oil prices hold above 105 dollars per barrel amid escalating U.S.-Iran geopolitical tensions affecting Middle East supply.
“What’s moving markets today?”
I see today's rally to new record highs, led by Apple's earnings beat, as evidence that AI-driven growth remains the dominant force in the market, keeping risk appetite strong and supporting elevated valuations in the tech sector. This environment should sustain favorable conditions for M&A and capital markets activity, even with the countervailing pressure from higher energy prices tied to Middle East developments.
Division at the Federal Reserve has traders placing bets on interest-rate cuts next year while also hedging for a hike in rates derivatives underlying the $31 trillion Treasury market.
Read lead storySpirit Airlines is preparing to shut down after a $500 million government bailout falters as the discount carrier runs low on cash and bondholders balk.
Seaport Therapeutics Inc. shares jumped 17% in the firm’s trading debut after the company raised nearly $255 million in an upsized initial public offering.
Brown University’s $8 billion endowment cut its position in a Blue Owl Capital Inc. private credit fund by more than half last quarter, joining retail investors in scaling back exposure to the $1.8 trillion market.
America’s biggest oil companies are warning that global crude markets may be nearing an inflection point of higher prices the longer the Strait of Hormuz stays closed.
Mercuria Energy Group has secured several agreements to purchase Venezuelan bulk commodities and metals, including gold, in the latest example of trading houses brokering investment deals in the country after former leader Nicolas Maduro’s ouster.
Work on the initial public offering of Navoi Mining & Metallurgical Co. has been paused as the Uzbek government weighs the right moment to list one of the world’s largest gold miners.
Agencies issue host state loan-to-deposit ratios.
An Illinois law set to go into effect this summer would ban interchange fees on taxes and tips, and has banks up in arms.
EQT AB has picked investment banks to advise on options for hearing aid maker WS Audiology, including a possible initial public offering in Copenhagen.
The iconic Venetian Resort Las Vegas is seeking to raise $2.35 billion from debt investors to refinance its capital structure, joining a flurry of high-yield deals as investor appetite for riskier debt rebounds.
Leo Pharma AS has picked more banks to help it prepare for a possible initial public offering in Copenhagen.
Traders on the Kalshi prediction markets platform think that the April 7 high of $113 in Western Texas Intermediate crude futures will likely be broken as the conflict drags on.
An unexpected pause in Colombia’s interest-rate hikes is threatening to upend local markets, with skepticism over the central bank’s credibility building weeks before a pivotal presidential election.
Crop shipments to Iran through the Strait of Hormuz have fallen more than 40% from March, with a prolonged US blockade threatening to worsen the country’s already high food inflation.
M&A
acquirer
Sun Pharmaceutical Industries Ltd
target
Organon & Co
OGN
$13.25
+55.2%
Strategic Rationale. Sun Pharma, a leading Indian generics giant, is acquiring Organon to diversify into higher-margin branded pharmaceuticals and women's health, expanding its global footprint with 70+ medicines across 140 countries and shifting away from low-margin generics.
Valuation & Premium Dynamics. The $14/share all-cash offer delivers a 24% premium to Organon's April 24 close, reflecting strategic control value and synergies. In pharma M&A, strategic buyers routinely pay such premiums for portfolio expansion and long-term accretion.
Cross-Border IB Nuances. Key execution risks include CFIUS/antitrust clearances, Indian FDI approvals, tax structuring, and global integration. Expect bulge-bracket advisors on fairness opinions, with the all-cash structure simplifying financing but highlighting balance-sheet strength.
The interview bank lives on a dedicated page so the homepage can stay focused on the daily market read.
Weekday drops, no account required. Market pulse, what to say about it, and the deal context worth repeating before the interview starts.